Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
8.62
-0.37 (-4.12%)
At close: Aug 10, 2026, 4:00 PM EDT
8.31
-0.31 (-3.60%)
After-hours: Aug 10, 2026, 7:49 PM EDT

Niki BioSolutions Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3.450.872.011.888.13
Short-Term Investments
---0.10.24
Cash & Short-Term Investments
3.450.872.011.998.37
Cash Growth
294.96%-56.41%1.02%-76.28%-73.76%
Accounts Receivable
--0.050.170.08
Other Receivables
--01.013.48
Total Trade Receivables
--0.051.183.56
Inventory
---0.030.04
Other Current Assets
0.140.090.423.870.72
Total Current Assets
3.590.962.487.0712.69
Net Property, Plant & Equipment
--1.853.173.89
Other Intangible Assets
--0.150.750.88
Long-Term Investments
15.115.116.19.744.16
Other Long-Term Assets
-0.070.070.130.3
Total Assets
18.6916.1320.6420.8721.91
Accounts Payable
1.1511.976.184.18
Short-Term Debt
3.42--3-
Current Portion of Long-Term Debt
---3.01-
Current Portion of Leases
0.020.10.130.310.19
Total Current Liabilities
4.594.342.112.54.38
Long-Term Debt
-3.243.060.5-
Long-Term Leases
-0.010.10.030.02
Other Long-Term Liabilities
0.31----
Total Long-Term Liabilities
0.313.253.160.530.02
Total Liabilities
4.94.355.2613.034.4
Common Stock
00035.7135.64
Additional Paid-in Capital
9793.4793.0245.3143.51
Accumulated Other Comprehensive Income
-0.090.09-0.010.03-0
Retained Earnings
-73.79-72.43-68.16-65.34-55.54
Total Common Shareholders' Equity
23.1221.1324.8515.7123.61
Minority Interest
-9.32-9.36-9.46-7.88-6.1
Shareholders' Equity
13.7411.7815.387.8317.51
Total Liabilities & Equity
18.6916.1320.6420.8721.91
Total Debt
3.443.353.286.850.22
Net Cash (Debt)
0.01-2.48-1.28-4.878.15
Net Cash Growth
-----72.08%
Net Cash Per Share
0.01-4.55-2.83-13.6423.27
Book Value
23.1221.1324.8515.7123.61
Book Value Per Share
31.4438.7654.9644.0267.38
Tangible Book Value
23.1221.1324.714.9622.73
Tangible Book Value Per Share
31.4438.7654.6341.9164.87